Yifan Pharmaceutical Co., Ltd. (SHE:002019)

China flag China · Delayed Price · Currency is CNY
13.72
-0.03 (-0.22%)
Sep 29, 2025, 11:44 AM CST
-0.22%
Market Cap16.73B
Revenue (ttm)5.16B
Net Income (ttm)436.39M
Shares Out1.22B
EPS (ttm)0.36
PE Ratio38.14
Forward PE26.96
Dividend0.10 (0.73%)
Ex-Dividend DateMay 29, 2025
Volume6,449,850
Average Volume20,006,436
Open13.75
Previous Close13.75
Day's Range13.56 - 13.93
52-Week Range9.98 - 16.66
Beta0.83
RSI34.14
Earnings DateOct 28, 2025

About Yifan Pharmaceutical

Yifan Pharmaceutical Co., Ltd. engages in the researches and develops, produces, and sells macromolecules, biosimilars, generic drugs, small molecules, synthetic biologics, and special traditional Chinese medicines in China Southeast Asia, Europe, North America, Singapore, South Korea, Italy, Germany, and the United States, and internationally. It offers oral slow controlled release preparations, micron suspensions, micelles for injection, and liquid preparations. The company also focuses on hematologic maliganancies, inflammatory, endocrinolog... [Read more]

Sector Healthcare
Founded 2000
Employees 4,098
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002019
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.